Prof. ÇİĞDEM SOYDAL

Publication Network

Articles 150

1. Comparative evaluation of the performance of 18F-PSMA-1007 PET/CT and 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence Evaluación comparativa de los resultados de la PET/TC con [18F]F-PSMA-1007 y la PET/TC con [68Ga]Ga-PSMA-11 en los pacientes con recidiva bioquímica de cáncer de próstata

Inal G., SOYDAL Ç., Demir B., ARAZ M., ÜRÜN Y., BALTACI S., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , vol.45, no.1, 2026 (SCI-Expanded, Scopus)

2. Safety of repeated trans-arterial radioembolization with multi-compartment dosimetry

SOYDAL Ç., Demir B., ARAZ M., Mesci I., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.

Annals of Nuclear Medicine , vol.39, no.12, pp.1306-1318, 2025 (SCI-Expanded, Scopus)

3. Prediction of [177Lu]Lu-PSMA-617 treatment response with [68Ga]Ga-PSMA-11 PET-derived variables and correlation of the overall survival with serum PSA and PSMA PET-based response criteria.

Ozkan E., Demir B., Soydal Ç., Araz M., Dursun E., Kucuk N. Ö., et al.

Revista espanola de medicina nuclear e imagen molecular , pp.500208, 2025 (Peer-Reviewed Journal)

4. Integrated Dedicated Liver ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging of Hepatocellular Carcinoma and Correlations of Positron Emission Tomography with Diffusion-Weighted Imaging and Morphological Findings

Soydal Ç., Demir B., Kuru Oz D., Dursun E., Araz M., Kucuk N. Ö.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2025 (SCI-Expanded, Scopus) Sustainable Development

5. Acute cytotoxic edema after radioembolization of the liver with Y-90 microspheres observed on DWI in post-therapy Y-90 PET/MRI

Demir B., Soydal Ç., Celebioglu E. C., Bilgic M. S., Oz D., Kucuk N. Ö.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.52, no.11, pp.3923-3925, 2025 (SCI-Expanded, Scopus) Sustainable Development

6. ⁶⁸Ga DOTATATE PET/MR Imaging of Well-Differentiated Primary and Metastatic Liver Neuroendocrine Tumors: Unified Evaluation and Correlations of PET, DCE, DWI, and T2-weighted Images

Soydal Ç., Demir B., Akkus Gunduz P., Baltacioglu M. H., Araz M., Kuru Oz D., et al.

CLINICAL NUCLEAR MEDICINE , vol.50, no.9, 2025 (SCI-Expanded, Scopus) Sustainable Development

7. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer

Dursun B., Demir B., Öksüz N. E., SOYDAL Ç., UTKAN G.

Journal of Clinical Medicine , vol.14, no.14, 2025 (SCI-Expanded, Scopus)

8. Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheres

Demir B., Kucuk N. Ö., Soydal Ç., Celebioglu E. C., Inal G., Dursun E., et al.

ANNALS OF NUCLEAR MEDICINE , vol.39, no.7, pp.716-731, 2025 (SCI-Expanded, Scopus) Sustainable Development

9. Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET: ARTE-MISO Trial

SOYDAL Ç., Demir B., ÇELEBİOĞLU E. C., DURSUN E., İNAL G., KÜÇÜK N. Ö., et al.

Clinical Nuclear Medicine , vol.50, no.7, 2025 (SCI-Expanded, Scopus)

10. Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival

SOYDAL Ç., ARAZ M., Demir B., ÖNEŞ T., SÖNMEZOĞLU K., Selcuk N. A., et al.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine , vol.66, no.7, pp.1097-1104, 2025 (SCI-Expanded, Scopus)

11. Granulomatous Inflammation of Liver Mimicking Malignancy on ⁶⁸Ga-FAPI PET/CT

ARAZ M., Dursun E., Mesci I., KONCA C., SOYDAL Ç., ÖZKAN E., et al.

CLINICAL NUCLEAR MEDICINE , vol.50, no.7, 2025 (SCI-Expanded, Scopus) Sustainable Development

12. Evaluation of the Effectiveness of Radioembolization Therapy in Colorectal Cancer Liver Metastases

KARAHACIOĞLU D., PEKER A., SOYDAL Ç., KÜÇÜK N. Ö., BİLGİÇ M. S.

New Trends in Medicine Sciences , vol.6, 2025 (TRDizin)

13. Clinical characteristics, risk stratifications, and long-term follow-up of childhood differentiated thyroid cancer: a single-center experience

Çetin S. K., AYCAN Z., ŞIKLAR Z., Fözsu E., FİTOZ Ö. S., Ceyhan K. A., et al.

ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.30, no.2, pp.86-94, 2025 (ESCI, Scopus) Sustainable Development

14. Prediction of left lobe hypertrophy with voxel-based dosimetry using integrated Y-90 PET/MRI after radioembolization of liver tumors with Y-90 microspheres

Demir B., Soydal Ç., Celebioglu E. C., Bilgic M. S., Kuru Oz D., Kir K. M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.52, no.5, pp.1695-1707, 2025 (SCI-Expanded, Scopus) Sustainable Development

15. Management Based on Pretreatment PSMA PET of Patients with Localized High-Risk Prostate Cancer Part 2: Prediction of Recurrence—A Systematic Review and Meta-Analysis

Hoffmann M. A., SOYDAL Ç., Virgolini I., TUNCEL M., Kairemo K., Kapp D. S., et al.

Cancers , vol.17, no.5, 2025 (SCI-Expanded, Scopus)

16. Long-term effect of postoperative radioactive iodine therapy on parathyroid function in patients with differentiated thyroid cancer

Avcı Merdin F., Gökçay Canpolat A., Çorapçıoğlu D., Soydal Ç., Şahin M.

Annals of Nuclear Medicine , vol.39, no.3, pp.278-284, 2025 (SCI-Expanded, Scopus)

17. Diagnostic performance of fluorine-18-fluorodeoxyglucose PET/MRI for detection of disease recurrence in differentiated thyroid cancer: a compartment-based analysis

Özkan E., Ünal S., Akkuş P., Peker E., Araz M., Dursun E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.46, no.3, pp.230-238, 2025 (SCI-Expanded, Scopus) Sustainable Development

18. Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres

Demir B., Soydal Ç., Kucuk N. Ö., Celebioglu E. C., Bilgic M. S., Kuru Oz D., et al.

Annals of Nuclear Medicine , vol.39, no.1, pp.31-46, 2025 (SCI-Expanded, Scopus)

19. PET/MR Imaging in Liver Tumors

KÜÇÜK N. Ö., SÜTÇÜ G., SOYDAL Ç.

NUCLEAR MEDICINE SEMINARS , vol.10, 2024 (Peer-Reviewed Journal)

20. PET/MR Imaging in Gynecological Malignancies

SOYDAL Ç., SÜTÇÜ G., KÜÇÜK N. Ö.

NUCLEAR MEDICINE SEMINARS , vol.10, 2024 (Peer-Reviewed Journal)

21. Imaging of Hypoxia in Liver Tumors With 18F-FMISO PET Before Selective Internal Radiotherapy With 90Y Microspheres.

SOYDAL Ç., DEMİR B., DURSUN E., Sutcu G., ÇELEBİOĞLU E. C., Sadik Bilgic M., et al.

Clinical nuclear medicine , vol.49, no.11, 2024 (SCI-Expanded, Scopus)

22. PET/MRI in Gynecologic Cancers: How Helpful is it?

ERDEN G. A., KURU ÖZ D., SOYDAL Ç., KÜÇÜK N. Ö.

Türk Radyoloji Seminerleri , 2024 (TRDizin)

23. De novo germline TP53 mutation in a pediatric patient with Li–Fraumeni syndrome and diffuse peritoneal mesothelioma

Ortaköylü M. Y., Özdemir S. İ., Dinçaslan H., Taçyıldız N., Ateş U., Ünal A. E., et al.

Pediatric Blood and Cancer , vol.71, no.8, 2024 (SCI-Expanded, Scopus)

24. Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature

ÇAĞLAR Y. Ş., Buyuktepe M., Sayaci E. Y., DOĞAN İ., BOZKURT M., PEKER E., et al.

DIAGNOSTICS , vol.14, no.14, 2024 (SCI-Expanded, Scopus) Sustainable Development

25. Prognostic Importance of 18F-FDG Positron Emission Tomography in Uterine Cervical Cancer

Soydal Ç., Baltacıoğlu M. H., Araz M., Demir B., Dursun E., Taşkın S., et al.

Molecular Imaging and Radionuclide Therapy , vol.33, no.3, 2024 (ESCI, TRDizin)

26. Demonstration of therapy response to radioembolization with ⁹⁰Y resin microspheres on ⁶⁸Ga-PSMA PET/MRI in a patient with hepatocellular carcinoma

Özkan E., Demir B., Kuru Öz D., Soydal Ç., Dursun E., Çelebioğlu E. C., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.51, no.1, pp.316-317, 2023 (SCI-Expanded, Scopus)

27. Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.

von Eyben R., Hoffmann M. A., Soydal Ç., Virgolini I., Tuncel M., Gauthé M., et al.

Biomedicines , vol.11, no.9, 2023 (SCI-Expanded, Scopus)

28. Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

Soydal Ç., Demir B., Sütçü G., Araz M., Küçük N. Ö.

Molecular imaging and radionuclide therapy , vol.32, no.2, pp.150-152, 2023 (ESCI, TRDizin)

29. The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions

ARAZ M., SOYDAL Ç., SÜTÇÜ G., Kivrak H., Sak S., KIR K. M., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.280, no.6, pp.2905-2910, 2023 (SCI-Expanded, Scopus)

30. The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.

Araz M., Soydal Ç., Demir Ö., Gökcan M. K., Küçük N. Ö.

Molecular imaging and radionuclide therapy , vol.32, no.1, pp.1-7, 2023 (ESCI, TRDizin)

31. Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study

Akkus Gunduz P., ÖZKAN E., KURU ÖZ D., SOYDAL Ç., ARAZ M., ERDEN G. A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.44, no.2, pp.150-160, 2023 (SCI-Expanded, Scopus) Sustainable Development

32. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis

Brown A. M., Kassab I., Massani M., Townsend W., Singal A. G., Soydal C., et al.

CANCER MEDICINE , vol.12, no.3, pp.2590-2599, 2023 (SCI-Expanded, Scopus)

33. Nivolumab for pediatric malignant peritoneal mesothelioma

YAMAN ORTAKÖYLÜ M., İNCESOY ÖZDEMİR S., DİNÇASLAN H., TAÇYILDIZ N., ÜNAL A. E., SOYDAL Ç., et al.

PEDIATRIC BLOOD & CANCER , vol.70, no.2, 2023 (SCI-Expanded, Scopus)

34. Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse

von Eyben R., Hoffmann M. A., Kapp D. S., SOYDAL Ç., Uprimny C., Virgolini I., et al.

EUROPEAN UROLOGY ONCOLOGY , vol.5, no.6, pp.732-733, 2022 (SCI-Expanded, SSCI, Scopus)

35. Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT

Schaefer N., Grözinger G., Pech M., Pfammatter T., SOYDAL Ç., Arnold D., et al.

Clinical Colorectal Cancer , vol.21, no.4, pp.285-296, 2022 (SCI-Expanded, Scopus)

36. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis

von Eyben R., Kapp D. S., Hoffmann M. A., SOYDAL Ç., Uprimny C., Virgolini I., et al.

CANCERS , vol.14, no.21, 2022 (SCI-Expanded, Scopus)

37. Clinical Features, Risk Classifications and Long-Term Follow Up Of Childhood Differentiated Thyroid Cancer (DTC): A Single Reference-Center Experience

AYCAN Z., Cetin S. K., ŞIKLAR Z., ÖZSU E., Fitoz S., CEYHAN K., et al.

HORMONE RESEARCH IN PAEDIATRICS , vol.95, no.SUPPL 2, pp.414, 2022 (SCI-Expanded, Scopus)

38. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer

KUBİLAY E., Akpinar Ç., OĞUZ E. S., ARAZ M., SOYDAL Ç., BALTACI S., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.40, no.9, 2022 (SCI-Expanded, Scopus)

39. Elevated Angiogenic Factor Levels After Transarterial Radioembolization for Colorectal Cancer Liver Metastases May Predict a Poor Prognosis

Soydal Ç., Araz M., Durmaz M., Özkan E., Ergüder B. İ., Küçük N. Ö., et al.

Molecular Imaging and Radionuclide Therapy , vol.31, no.2, pp.114-122, 2022 (Scopus, TRDizin) Sustainable Development

40. Combined clinical and specific positron emission tomography/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups

ÖZKAN E., ORHAN K., SOYDAL Ç., KAHYA Y., Seckin Tunc S., ÇELİK Ö., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.43, no.5, pp.529-539, 2022 (SCI-Expanded, Scopus)

41. Detectability of 18F-choline PET/MR in primary hyperparathyroidism

Araz M., Nak D., Soydal Ç., Peker E., Erden İ., Küçük N. Ö.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.279, no.5, pp.2583-2589, 2022 (SCI-Expanded, Scopus)

42. Aumento difuso de la captación en los conductos biliares intrahepáticos en18F-FDG-PET/TC en un caso de colangitis esclerosante primaria

Araz M., Gündüz P., Baltacıoğlu M. H., Soydal Ç., Kır K. M.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.41, pp.4-5, 2022 (SCI-Expanded, Scopus)

43. Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer

Araz M., Soydal Ç., Özkan E., Sen E., Nak D., Kucuk O. N., et al.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.66, no.1, pp.61-66, 2022 (SCI-Expanded, Scopus)

44. Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma

Araz M., Özkan E., Gündüz P., Soydal Ç., Küçük N. Ö., Kır K. M.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, pp.56-62, 2022 (SCI-Expanded, Scopus)

45. Myocardial perfusion SPECT findings in postCOVID period

Araz M., Soydal Ç., Sütçü G., Demir B., Özkan E.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.3, pp.889-894, 2022 (SCI-Expanded, Scopus)

46. Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1, pp.49-56, 2022 (ESCI, Scopus, TRDizin)

47. Hepatobiliary Scintigraphy

SÜTÇÜ G., SOYDAL Ç.

NUCLEAR MEDICINE SEMINARS , vol.8, 2022 (Peer-Reviewed Journal)

48. Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma

SOYDAL Ç., VARLI B., ARAZ M., BAKIRARAR B., TAŞKIN S., ORTAÇ U. F.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, pp.762-769, 2022 (SCI-Expanded, Scopus, TRDizin)

49. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer

Soydal Ç., Araz M., Ürün Y., Nak D., Özkan E., Küçük N. Ö.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3, pp.282-286, 2021 (SCI-Expanded, Scopus)

50. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters

Araz M., Soydal Ç., Özkan E., Akkus P., Nak D., Küçük N. Ö., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.36, no.5, pp.425-432, 2021 (SCI-Expanded, Scopus)

51. Ga-68-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy

von Eyben F. E., SOYDAL Ç., von Eyben R.

DIAGNOSTICS , vol.11, no.4, 2021 (SCI-Expanded, Scopus)

52. Three dimensional modeling and quantitative analysis of long bone parameters of rabbit using micro-computed tomography

Bakici C., Akgun R. O., Ekim O., Batur B., Bakici M., ÖZEN D., et al.

IRANIAN JOURNAL OF VETERINARY RESEARCH , vol.22, no.2, pp.140-145, 2021 (SCI-Expanded, Scopus)

53. The prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in patients with malignant pleural mesothelioma

YENİGÜN B. M., KAHYA Y., SOYDAL Ç., Tutkun N. A., KOCAMAN G., KOÇAK E. M., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY , vol.29, no.1, pp.93-101, 2021 (SCI-Expanded, Scopus, TRDizin)

54. Lymph node mapping in gastric cancer surgery: current status and new horizons

Zulfikaroglu B., KÜÇÜK N. Ö., SOYDAL Ç., Ozmen M.

TURKISH JOURNAL OF SURGERY , vol.36, no.4, pp.393-398, 2020 (ESCI, Scopus, TRDizin)

55. F-18 FDG PET/CT Practice Guideline in Oncology

SOYDAL Ç., BURAK Z., UÇMAK G., BOZKURT M. F., ATASEVER T., DEMİRCİ E., et al.

Nuclear Medicine Seminars , vol.6, no.3, pp.339-357, 2020 (Peer-Reviewed Journal)

56. Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis

von Eyben F. E., Bauman G., von Eyben R., Rahbar K., SOYDAL Ç., Haug A. R., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.21, no.23, 2020 (SCI-Expanded, Scopus)

57. Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol 2020;77:508-47

Von Eyben F. E., Bauman G., Soydal Ç., Paganelli G.

EUROPEAN UROLOGY , vol.78, no.5, 2020 (SCI-Expanded, Scopus) Sustainable Development

58. Volumetric analysis of the cranial and nasal cavity from micro-computed tomography scans in the rabbit

BAKICI C., Akgun R. O., Ekim O., Soydal Ç., Oto Ç.

Folia Morphologica (Poland) , vol.79, no.2, pp.333-338, 2020 (SCI-Expanded, Scopus)

59. Predictor of Ga-68 PSMA PET/CT positivity in patients with prostate cancer

Soydal Ç., Ürün Y., Süer E., Nak D., Özkan E., Küçük N. Ö.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.64, no.2, pp.226-230, 2020 (SCI-Expanded, Scopus) Sustainable Development

60. Complementary role of F-18-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis

TAŞKIN S., VARLI B., CANSIZ ERSÖZ C., Altin D., SOYDAL Ç., Ortac F.

NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.4, pp.389-394, 2020 (SCI-Expanded, Scopus) Sustainable Development

61. Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

SOYDAL Ç., AKKUŞ P., ARAZ M., UTKAN G.

Molecular Imaging and Radionuclide Therapy , vol.29, no.2, pp.79-81, 2020 (ESCI, Scopus, TRDizin)

62. Incidental F-18-Fluorocholine Uptake in an Esophageal Diverticulum F-18-FCH in an Esophageal Diverticulum

Araz M., Cinel M., Soydal Ç., Özkan E., Küçük N. Ö.

CLINICAL NUCLEAR MEDICINE , vol.45, no.4, 2020 (SCI-Expanded, Scopus)

63. Photocatalytically Active Graphitic Carbon Nitride as an Effective and Safe 2D Material for In Vitro and In Vivo Photodynamic Therapy

Taheri H., Ünal M. A., Sevim M., Gurcan C., Ekim O., Ceylan A., et al.

SMALL , no.10, 2020 (SCI-Expanded, Scopus)

64. Developments in Pain Imaging

Soydal Ç., Araz M.

Nuclear Medicine Seminars , vol.6, no.1, pp.1-4, 2020 (Peer-Reviewed Journal)

65. Procedur Guideline for Lymphoscintigraphy and Sentinel Lymph Node in Breast Cancer

UÇMAK G., DEMİREL B. B., BOZKURT M. F., AK SİVRİKOZ İ., BURAK Z., SOYDAL Ç., et al.

Nuclear Medicine Seminars , vol.6, 2020 (Peer-Reviewed Journal) Sustainable Development

66. Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma

Soydal Ç., Araz M., Nak D., Akku P., Baltacıoğlu M. H., Bilgic S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.1, pp.73-77, 2020 (SCI-Expanded, Scopus)

67. Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings

Gülpınar B., Peker E., Soydal Ç., Araz M., Elhan A. H.

BRITISH JOURNAL OF RADIOLOGY , vol.93, no.1106, 2020 (SCI-Expanded, Scopus)

68. Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma

BOZKURT M. F., UÇMAK G., AK SİVRİKOZ İ., BURAK Z., SOYDAL Ç., ATASEVER T., et al.

Nuclear Medicine Seminars , vol.6, 2020 (Peer-Reviewed Journal)

69. An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT

Araz M., Soydal Ç., Ozturk C., Özkan E., Demirer T.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.47, no.1, pp.218-219, 2020 (SCI-Expanded, Scopus)

70. F-18 FDG PET/CT Practice Guideline in Oncology: Assesment of Treatment Response

ATASEVER T., DEMİRCİ E., SOYDAL Ç., BURAK Z., UÇMAK G., BOZKURT M. F., et al.

Nuclear Medicine Seminars , vol.6, 2020 (Peer-Reviewed Journal)

71. Treatment Management with 18F-Fluoro-L-DOPA PET/CT Imaging of Focal Congenital Hyperinsulinemic Hypoglycemia Case

KIZILCAN Ç. S., ERGEN IŞIKLAR Z., SOYDAL Ç., ÖZSU E., AYCAN Z., YAĞMURLU E. A., et al.

Turkiye Klinikleri Journal of Pediatrics , vol.29, no.3, pp.187-194, 2020 (Scopus, TRDizin)

72. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma

Soydal Ç., Nak D., Araz M., Akkus P., Ürün Y., Özkan E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.40, no.12, pp.1243-1249, 2019 (SCI-Expanded, Scopus)

73. F-18-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value

Soydal Ç., Araz M., Ürün Y., Gülpınar B., Nak D., Özkan E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.40, no.12, pp.1268-1274, 2019 (SCI-Expanded, Scopus)

74. Ga-68-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor

Soydal Ç., Nak D., Araz M., Demirkazık A., Küçük N. Ö.

CLINICAL NUCLEAR MEDICINE , vol.44, no.10, pp.795-796, 2019 (SCI-Expanded, Scopus)

75. Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial

Konert T., Vogel W. V., Paez D., Polo A., Fidarova E., Carvalho H., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.46, no.11, pp.2235-2243, 2019 (SCI-Expanded, Scopus)

76. Case Report and Review of Literature: Patient with Malignant Pheochromocytoma

GÜRBÜZ M., ÖZYURT N., KOCAAY A. F., SOYDAL Ç., ÇAY ŞENLER F.

Journal of Ankara University Faculty of Medicine , vol.72, no.2, pp.251-253, 2019 (TRDizin)

77. Intense Pituitary 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake in a Patient with Diabetes Insipidus

Soydal Ç., Nak D., Araz M., Taçyıldız N., Küçük N. Ö.

BALKAN MEDICAL JOURNAL , vol.36, no.4, pp.253-254, 2019 (SCI-Expanded, Scopus, TRDizin)

78. Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma

SOYDAL Ç., ÖZKAN E., Nak D., ELHAN A. H., KÜÇÜK N. Ö., KIR K. M.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.2, pp.69-75, 2019 (ESCI, Scopus, TRDizin) Sustainable Development

79. 177Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer

Von Eyben F. E., Singh A., Zhang J., Nipsch K., Meyrick D., Lenzo N., et al.

Oncotarget , vol.10, no.25, pp.2451-2461, 2019 (SCI-Expanded, Scopus)

80. Evaluation of Chemokine Receptor-4 Expression by 68Ga-Pentixafor PET/CT in Patients with Multiple Myeloma

ÖZKAN E., SOYDAL Ç., Sahin U., BEKSAÇ M., Ozturk C., CİVRİZ BOZDAĞ S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.29, no.4, pp.210-218, 2019 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

81. The efficacy of fluorine-18-choline PET/CT in comparison with Tc-99m-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism

Araz M., Soydal Ç., Özkan E., Kır K. M., İbiş E., Güllü S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11, pp.989-994, 2018 (SCI-Expanded, Scopus)

82. Positron Emission Tomography in Renal Cell Carcinoma

SOYDAL Ç., ÜRÜN Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.17, no.2, pp.68-72, 2018 (ESCI, TRDizin)

83. Karaciğer tümörlerinde intraarteriyel Y-90 mikroküre tedavi uygulamaları, yan etkiler ve hasta takibi

ÖZKAN E., SOYDAL Ç.

Türkiye Klinikleri , pp.23-25, 2018 (TRDizin)

84. Dynamic risk stratification for predicting the recurrence in differentiated thyroid cancer

ÖZKAN E., SOYDAL Ç., Nak D., KÜÇÜK N. Ö., KIR K. M.

NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.12, pp.1055-1059, 2017 (SCI-Expanded, Scopus) Sustainable Development

85. Comparison of 18F-FDG PET/CT and ceCT results in the assesment of RCC recurrence

ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.

Studies on Stem Cells Research and Therapy , vol.3, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)

86. Sentinel Lymph Node Biopsy for Gastrointestinal Cancers

BİRBEN B., ÖZKAN E., ZÜLFİKAROĞLU B., SOYDAL Ç., TEZ M., KÜÇÜK N. Ö.

Nükleer Tıp Seminerleri , vol.3, no.2, pp.129-139, 2017 (Peer-Reviewed Journal) Sustainable Development

87. Ga-68 PSMA Accumulation in Hepatocellular Carcinoma

SOYDAL Ç., ALKAN A., ÖZKAN E., DEMİRKAZIK A., KÜÇÜK N. Ö.

Journal of Gastroenterology, Pancreatology Liver Disorders , vol.4, no.2, pp.1, 2017 (Peer-Reviewed Journal)

88. Functional compared to anatomical imaging in the initial evaluation of patients with suspected coronary artery disease: An international, multi-center, randomized controlled trial (IAEA-SPECT/CTA study)

Karthikeyan G., Salobir B. G., Jug B., Devasenapathy N., Alexanderson E., Vitola J., et al.

JOURNAL OF NUCLEAR CARDIOLOGY , vol.24, no.2, pp.507-517, 2017 (SCI-Expanded, Scopus)

89. Is Routine Diagnostic Radioiodine Whole-Body Scintigraphy Needed in Patients who Received Ablative doses of Radioiodine for Differentiated Thyroid Carcinoma?

SOYDAL Ç., ÖZKAN E., NAK D., KÜÇÜK N. Ö., KIR K. M.

International Journal of Nuclear Medicine Research , vol.4, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)

90. Preoperative F-18-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients

Atakul B. K., TAŞKIN S., SOYDAL Ç., ŞÜKÜR Y. E., Kahraman A., Koyuncu K., et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.82, no.4, pp.340-348, 2017 (SCI-Expanded, Scopus) Sustainable Development

91. Comparison of 18F-FDG PET/CT and ceCT results in the assessment of RCC recurrence

ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.

Studies on Stem Cells Research and Thearpy , vol.3, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)

92. Pediatrik Olgularda Tiroid Kanserleri

ÖZKAN E., SOYDAL Ç.

Turkiye Klinikleri J Nucl Med-Special Topics , vol.3, no.1, pp.71-76, 2017 (TRDizin) Sustainable Development

93. Widespread Metastatic Involvement in a Patient with Merkel Cell Carcinoma on 68Ga-DOTATATE PET/CT: Case Report

ÖZKAN E., SOYDAL Ç., ALKAN A., UTKAN G.

Turkiye Klinikleri Journal of Case Reports , vol.25, no.1, pp.10-13, 2017 (TRDizin)

94. May preablative thyroglobulin level be a prognostic indicator for papillary thyroid cancer?

ÖZKAN E., SOYDAL Ç., ARAZ M., GENÇ Y., KÜÇÜK N. Ö.

Clinical and Medical Investigations , vol.2, no.1, pp.1-16, 2017 (Peer-Reviewed Journal)

95. Prognostic Importance of Bone Marrow Uptake on Baseline F-18-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma

SOYDAL Ç., KÖKSOY E. B., Yasar A., Turgal E., DOĞANAY ERDOĞAN B., AKBULUT H., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.31, no.10, pp.361-365, 2016 (SCI-Expanded, Scopus)

96. Intra-pancreatic Accessory Spleen Mimicking Pancreatic Neuroendocrine Tumor on 68-Ga-Dotatate PET/CT

Bostanci E. B., Oter V., Okten S., KÜÇÜK N. Ö., SOYDAL Ç., Turhan N., et al.

ARCHIVES OF IRANIAN MEDICINE , vol.19, no.11, pp.816-819, 2016 (SCI-Expanded, Scopus)

97. Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis

SOYDAL Ç., KÜÇÜK N. Ö., BALCI D., GEÇİM İ. E., Bilgic S., ELHAN A. H.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.31, no.9, pp.342-346, 2016 (SCI-Expanded, Scopus) Sustainable Development

98. Demonstration of Response to Androgen Deprivation Therapy by Ga-68-PSMA PET/CT

SOYDAL Ç., ÖZKAN E., Kaya B., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE , vol.41, no.10, pp.794-796, 2016 (SCI-Expanded, Scopus) Sustainable Development

99. Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor

ÖZKAN E., SOYDAL Ç., Semirgin S. U., Yapici O., ATMACA A., Demirag G.

CLINICAL NUCLEAR MEDICINE , vol.41, no.7, pp.561-563, 2016 (SCI-Expanded, Scopus)

100. Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients

SOYDAL Ç., Arslan M. F., KÜÇÜK N. Ö., İDİLMAN R., Bilgic S.

NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.6, pp.646-649, 2016 (SCI-Expanded, Scopus) Sustainable Development

101. Assessment of Gastric Emptying in Patients with Autoimmune Gastritis

Kalkan C., Soykan I., SOYDAL Ç., ÖZKAN E., Kalkan E.

DIGESTIVE DISEASES AND SCIENCES , vol.61, no.6, pp.1597-1602, 2016 (SCI-Expanded, Scopus)

102. Relationships between autonomic nerve function and gastric emptying in patients with autoimmune gastritis

Kalkan C., SOYDAL Ç., ÖZKAN E., Maden A., Soykan I.

CLINICAL AUTONOMIC RESEARCH , vol.26, no.3, pp.189-196, 2016 (SCI-Expanded, Scopus)

103. Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT

SOYDAL Ç., ÖZKAN E., Yerlikaya H., UTKAN G., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE , vol.41, no.6, 2016 (SCI-Expanded, Scopus)

104. Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?

TAÇYILDIZ N., Tanyildiz H. G., DİNÇASLAN H., Yavuz G., ÜNAL E., ÖZKAN E., et al.

IRANIAN JOURNAL OF PEDIATRICS , vol.26, no.2, 2016 (SCI-Expanded, Scopus)

105. Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer

SOYDAL Ç., ÖZKAN E., AKYÜREK S., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE , vol.41, no.2, pp.159-160, 2016 (SCI-Expanded, Scopus) Sustainable Development

106. Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

International Journal of Nuclear Medicine Research , vol.3, 2016 (Peer-Reviewed Journal)

107. Radioembolization with Y-90 resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors

SOYDAL Ç., KÜÇÜK N. Ö., Bilgic S., İBİŞ E.

ANNALS OF NUCLEAR MEDICINE , vol.30, no.1, pp.29-34, 2016 (SCI-Expanded, Scopus)

108. Ga 68 DOTATATE positron emission tomography computed tomography findings in patients with neuroendocrine tumor suspicion

SOYDAL Ç., ÖZKAN E., BALİ ATAŞ E., KÜÇÜK N. Ö., KIR K. M.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.69, no.1, pp.7-10, 2016 (TRDizin)

109. Effect of the application of prophylactic central compartment lymph node dissection on radioiodine ablation doses in patients with papillary thyroid carcinoma

SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.4, pp.1078-1082, 2016 (SCI-Expanded, Scopus, TRDizin)

110. Impact of 18F FDG PET CT for detecting primary tumor focus in patients with histopathologically proven metastasis

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

International Journal of Nuclear Medicine Research , vol.3, pp.56-62, 2016 (Peer-Reviewed Journal)

111. Radyoaktif tedavi sonrası tedaviye yanıtın değerlendirilmesi Kemik metastazları ve radyosinovektomi tedavileri sonrası

KÜÇÜK N. Ö., SOYDAL Ç.

Türkiye Klinikleri Journal of Nuclear Medicine-Special Topics , vol.2, no.1, pp.216-221, 2016 (TRDizin)

112. The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of response to fixed-dose peptide receptor radionuclide therapy with Lu-177 DOTATATE

SOYDAL Ç., Peker A., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.2, pp.409-413, 2016 (SCI-Expanded, Scopus, TRDizin)

113. F-18-NaF Positive Bone Metastases of Non F-18-FDG Avid Mucinous Gastric Cancer

Soydal Ç., Özkan E., Küçük N. Ö., Kır K. M.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.24, no.3, pp.132-134, 2015 (ESCI, TRDizin) Sustainable Development

114. Ga-68 DOTATATE Accumulation in Sarcoidosis

SOYDAL Ç., KÜÇÜK N. Ö., ÖZKAN E., ÖZDEMİR KUMBASAR Ö., KIR K. M.

International Journal of Nuclear Medicine Research , vol.2, no.2, pp.1-4, 2015 (Peer-Reviewed Journal)

115. Theranostics in Neuroendocrine Tumors

ÖZKAN E., SOYDAL Ç.

Nükleer Tıp Seminerleri , vol.1, no.2, pp.103-108, 2015 (Peer-Reviewed Journal)

116. Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy

SOYDAL Ç., Keskin O., KÜÇÜK N. Ö., ÖZKAN E., Bilgic S., İDİLMAN R., et al.

ANNALS OF NUCLEAR MEDICINE , vol.29, no.5, pp.426-430, 2015 (SCI-Expanded, Scopus) Sustainable Development

117. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment

SOYDAL Ç., ARAZ M., ÖZKAN E., Arslantas E., KÜÇÜK N. Ö., Aras G.

NUCLEAR MEDICINE COMMUNICATIONS , vol.36, no.2, pp.109-113, 2015 (SCI-Expanded, Scopus)

118. The Role of F-18-FDG PET/CT in the Primary Staging of Gastric Cancer

Filik M., KIR K. M., Aksel B., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.24, no.1, pp.15-20, 2015 (ESCI, TRDizin) Sustainable Development

119. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases

Peker A., Cicek O., SOYDAL Ç., KÜÇÜK N. Ö., Bilgic S.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , vol.21, no.1, 2015 (SCI-Expanded, Scopus, TRDizin)

120. The role of 18F FDG PET CT in the primary staging of gastric cancer

FİLİK M., KIR K. M., AKSEL B., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., et al.

Molecular Imaging and Radionuclide Therapy , vol.24, no.1, pp.15-20, 2015 (TRDizin) Sustainable Development

121. Systemic Radiopharmaceutical Agents (Sm-153) may be Dangerous in Hepatacellular Carcinoma

KESKİN O., SOYDAL Ç., DEDA X., MANTI B., TÜZÜN A. E.

World Journal of Nuclear Medicine , vol.14, no.1, pp.51, 2015 (ESCI)

122. Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging

KÖROĞLU R., ÖZKAN E., SOYDAL Ç., İBİŞ E.

International Journal of Nuclear Medicine Research , vol.2, pp.1-6, 2015 (Peer-Reviewed Journal) Sustainable Development

123. Assessment of Sorafenib and AntiVEGF Combination Therapy Response which Added to Neoadjuvant Therapy in two Pediatric Metastatic Ewing Sarcoma Patients by Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography 18F PET Method It may Determine the Prognosis

TAÇYILDIZ N., TANYILDIZ G., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö., YAVUZ L. G., et al.

Journal of Nuclear Medicine & Radiation Therapy , vol.6, no.02, 2015 (Peer-Reviewed Journal)

124. Nöroendokrin tümörlerde moleküler görüntüleme

ÖZKAN E., SOYDAL Ç.

Türkiye Klinikleri J Nucl Med-Special Topics , vol.1, no.1, pp.95-101, 2015 (Peer-Reviewed Journal)

125. Selective internal radiotherapy for hepatic epithelioid hemangioendothelioma

Bostanci E. B., Karaman K., Turhan N., Dalgic T., Ozer I., SOYDAL Ç., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, pp.252-253, 2014 (SCI-Expanded, Scopus, TRDizin)

126. The Role of 18F-Flourodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) in Pelvic and Paraaortic Lymph Node Staging of Uterine Cervical Cancer

SOYDAL Ç., İBİŞ E., ORTAÇ F., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.

International Journal of Nuclear Medicine Research , vol.1, no.1, pp.1-6, 2014 (Peer-Reviewed Journal) Sustainable Development

127. Prognostic Value of Metabolic Tumor Volume Measured by F-18-FDG PET/ CT in Esophageal Cancer Patients

SOYDAL Ç., YÜKSEL C., KÜÇÜK N. Ö., Okten I., ÖZKAN E., Erdogan B. D.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.23, no.1, pp.12-15, 2014 (ESCI, TRDizin)

128. The role of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer

Ozis S. E., SOYDAL Ç., AKYOL C., Can N., KÜÇÜK N. Ö., YAĞCI C., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.12, 2014 (SCI-Expanded, Scopus)

129. Alternatif hızlı maksiller genişletme ve daraltmanın sirkummaksiller süturalar üzerine etkisinin 99mTc-MDP spect kemik sintigrafisi ile değerlendirilmesi

GÖKALP H., SOYDAL Ç., SAMUROĞLU R., AYDIN MUSTAFA F.

Ankara Üniversitesi Diş Hekimliği Fakültesi Dergisi , vol.41, no.2, pp.69-76, 2014 (TRDizin)

130. Prognostic value of metabolic tumor volume measured by 18F FDG PET CT in esophageal cancer patients

SOYDAL Ç., YÜKSEL C., KÜÇÜK N. Ö., ÖKTEN İ., ÖZKAN E., DOĞANAY ERDOĞAN B.

Molecular Imaging and Radionuclide Therapy , vol.23, no.1, pp.12-15, 2014 (TRDizin) Sustainable Development

131. The role of 18F Flourodeoxyglucose 18F FDG positron emission tomography computed tomography PET CT in pelviv and paraaortic lymph node stageng of uterine cervical cancer

SOYDAL Ç., İBİŞ E., ORTAÇ F., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.

Internationl Journal of Nuclear Medicine Research , vol.1, pp.1-6, 2014 (Peer-Reviewed Journal) Sustainable Development

132. Rationale of Radioembolization in Intermediate and Advanced Stage Hepatocellular Cancer

SOYDAL Ç.

Journal of Gastroenterology, Pancreatology & Liver Disorders , vol.1, no.2, pp.1-2, 2014 (Peer-Reviewed Journal) Sustainable Development

133. Ga-68 Labeled Somatostatin Analogs Positron Emission Tomography/ Computed Tomography in Gastroenteropancreatic Neuroendocrine Tumors

SOYDAL Ç.

Journal of Gastroenterology, Pancreatology & Liver Disorders , vol.1, no.1, pp.1-4, 2014 (Peer-Reviewed Journal)

134. Prognostic Importance of F-18-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., Bilgic S., İBİŞ E.

CLINICAL NUCLEAR MEDICINE , vol.38, no.7, 2013 (SCI-Expanded, Scopus) Sustainable Development

135. The prognostic value of quantitative parameters of F-18-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer

SOYDAL Ç., KÜÇÜK N. Ö., GEÇİM İ. E., Bilgic S., ELHAN A. H.

NUCLEAR MEDICINE COMMUNICATIONS , vol.34, no.5, pp.501-506, 2013 (SCI-Expanded, Scopus) Sustainable Development

136. Evaluation of the Response to Selective Internal Radiation Therapy in Patients With Hepatocellular Cancer According to Pretreatment Tc-99m-MAA Uptake

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., Aras G.

CLINICAL NUCLEAR MEDICINE , vol.38, no.4, pp.252-255, 2013 (SCI-Expanded, Scopus) Sustainable Development

137. Intense Ga-68 Dotatate Uptake in Recurrent MTC Patient

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.

World Journal of Endocrine Surgery , vol.4, no.3, pp.118-119, 2012 (Scopus)

138. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G.

NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.9, pp.990-994, 2012 (SCI-Expanded, Scopus) Sustainable Development

139. Unexpected F-18-FDG uptake in an ocular prosthesis

ÖZKAN E., ARAZ M., SOYDAL Ç., Aras G.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.39, no.9, pp.1517-1518, 2012 (SCI-Expanded, Scopus)

140. The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.

CLINICAL NUCLEAR MEDICINE , vol.37, no.8, pp.755-758, 2012 (SCI-Expanded, Scopus) Sustainable Development

141. Detection of Intraluminal Tracheal Metastasis of Thyroid Papillary Carcinoma by F-18-FDG PET/CT

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E.

CLINICAL NUCLEAR MEDICINE , vol.37, no.6, 2012 (SCI-Expanded, Scopus)

142. The role of F-18-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels

ÖZKAN E., SOYDAL Ç., ARAZ M., KIR K. M., İBİŞ E.

NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.4, pp.395-402, 2012 (SCI-Expanded, Scopus) Sustainable Development

143. Clinical Experience of F-18-FDG PET/CT in Soft Tissue and Osseous Sarcomas

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.3, pp.163-169, 2012 (SCI-Expanded, Scopus, TRDizin)

144. The role of intraoperative gamma probe and parathyroid hormone measurement in the localization of intrathyroidal parathyroid adenoma

SOYDAL Ç., GENÇ V., ARAZ M., AKYOL C., KÜÇÜK N. Ö.

World Journal of Endocrine Surgery , vol.4, no.2, pp.77-78, 2012 (Scopus)

145. Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma

ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E., Erbay G.

Nuclear Medicine Communications , vol.32, no.12, pp.1162-1168, 2011 (SCI-Expanded, Scopus) Sustainable Development

146. Differentiated thyroid carcinomas in childhood: clinicopathologic results of 26 patients

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.24, no.9-10, pp.739-742, 2011 (SCI-Expanded, Scopus) Sustainable Development

147. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors

KÜÇÜK N. Ö., SOYDAL Ç., Lacin S., ÖZKAN E., Bilgic S.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.9, 2011 (SCI-Expanded, Scopus)

148. The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer: Comparison with spiral CT

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.9, 2011 (SCI-Expanded, Scopus)

149. Differentiated thyroid corcinomas in childhood: clinicopathologic results of 26 patients

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.

Journal of Pediatric Endocrinology and Metabolism , vol.24, no.9-10, pp.739-742, 2011 (Peer-Reviewed Journal)

150. Ocular involvement in mantle cell lymphoma detected by F 18 FDG PET CT

Özkan E., Laçin S., Soydal Ç., Araz M., Küçük N. Ö.

Molecular Imaging and Radionuclide Therapy , vol.20, no.1, pp.36-37, 2011 (TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 166

1. Interim Analysis of Effect of Hypoxia on F-18 MISO PET to Response to Lu-177 PSMA Treatment (LuMISO)Trial

SOYDAL Ç., DURSUN E., DEMİR B., SÜTÇÜ G., ARAZ M., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

2. Dose-Response Relationship in Patients Who Received TARE with Y-90 Resin Microspheres for Hepatocellular Carcinoma

SOYDAL Ç., DURSUN E., MESCİ İ., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

3. Variations in F-18-FMISO Physiological Uptake

ARAZ M., MESCİ İ., DURSUN E., SOYDAL Ç., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

4. Correlation Between PRIMARY Scores in Ga-68 PSMA PET and Histological ISUP Grades in Prostate Cancer

SOYDAL Ç., ÇİDEMAL M., ARAZ M., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

5. Quantitative Tc-99m MIBI SPECT/CT parameters can predict malignancy in indeterminate thyroid nodulespreliminary results

ARAZ M., MESCİ İ., DURSUN E., SOYDAL Ç., AKSU O., ERASLAN E., et al.

Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

6. LOKAL İLERI MEME KANSERINDE NEOADJUVAN TEDAVI SONRASI METABOLIK YANIT ILE PATOLOJIK TAM YANIT İLIŞKISI

Dursun B., Yaşar H. A., Soydal Ç., Demirkazık A.

11. Türk Tıbbi Onkoloji Kongresi, Girne, Cyprus (Kktc), 24 April - 28 November 2024, pp.100, (Summary Text)

7. Pankreasta ve Uterusta Fizyolojik Ga-68 FAPİ Tutulumu

MESİCİ İ., SOYDAL Ç., DURSUN E., ARAZ M., KÜÇÜK N. Ö.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

8. Karaciğer Tümörlerinin Y-90 Reçine Mikroküreler ile Tedavisi Sonrasında Y-90 PET/MR Görüntülemede Solunum Gating’inin Kullanımı ve Dozimetriye Etkisi

DEMİR B., SOYDAL Ç., MESCİ İ., ÇELEBİOĞLU E. C., BİLGİÇ M. S., KURU ÖZ D., et al.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

9. Çok Kompartmanlı Dozimetri ile Tekrarlayan Transarteriyel Radyoembolizasyonun Güvenilirliği

SOYDAL Ç., DEMİR B., ARAZ M., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

10. F-18 FES PET’in Metastatik Meme Kanserinde Östrojen Reseptör Heterojenitesinin Gösterilmesindeki Yeri

DURSUN E., ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., ARAZ M., DEMİR B., et al.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

11. Plevral Mezotelyomada İmmünoterapi Öncesi Ga-68 FAPI PET’nin Prognostik Önemi (FAPBI Trial): Ön Sonuçlar

SOYDAL Ç., MESCİ İ., KÜÇÜK N. Ö., KAYI CANGIR A., DURSUN Ş., KARAKAYA S., et al.

37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

12. Klinik Evre 1 Akciğer Kanserinde 18F-FDG PET/BT Parametreleri ile STAS'ın Öngörülmesi

Kocaman G., Soydal Ç., Dursun Ş., Kahya Y., Sak S., Kayı Cangır A.

XI. Ulusal Akciğer Kanseri Kongresi, Antalya, Turkey, 28 November - 01 December 2024, pp.52-53, (Summary Text)

13. F18-FCH uptake in thyroid parenchymal diseases

ARAZ M., SOYDAL Ç., DEMİR B., SÜTÇÜ G., GÖKÇAY CANPOLAT A., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.367-368, (Full Text)

14. Interim analysis Assessment of Hypoxia before radioembolization treatment with 18F-FMISO PET (ARTE-MISO Tiriol)

SOYDAL Ç., DEMİR B., ÇELEBİOĞLU E. C., SÜTÇÜ G., BİLGİÇ M. S., KÜÇÜK N. Ö.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.408-409, (Full Text)

15. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

ARAZ M., SOYDAL Ç., DURSUN E., MESCİ İ., KONCA C., ÖZKAN E., et al.

Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.17, (Full Text)

16. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

ARAZ M., SOYDAL Ç., DURSUN E., Mesci İ., KONCA C., ÖZKAN E., et al.

Annual Congress of the European Association of Nuclear Medicine October 19–23, 2024 Hamburg, Germany, Hamburg, Germany, 19 October 2024, vol.51, pp.17, (Summary Text)

17. Biyokimyasal nüks izlenen prostat Ca hastalarında F-18 PSMA PET/BT'nin başarısının değerlendirilmesi.

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.

36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)

18. Lu-177 PSMA tedavisine yanıtın RECIP kriterleri ve PSA düzeyi ile değerlendirilmesi ve sağkalım ile korelasyonu

ÖZKAN E., DEMİR B., SOYDAL Ç., DURSUN E., ARAZ M., ÜRÜN Y., et al.

36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)

19. Transarteriyel radyoembolizasyon öncesi hipoksinin F-18 FMISO/PET ile değerlendirilmesi (ARTE-MISO Trial): Ön Bulgular

SOYDAL Ç., DEMİR B., ÇELEBİOĞLU E. C., SÜTÇÜ G., KÜÇÜK N. Ö., BİLGİÇ M. S.

36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)

20. Tare uygulanan hastalarda sol lob hipertrofisinin Y-90 PET/MRG ile yapılan voksel temelli dozimetri ile korelasyonu

DEMİR B., SOYDAL Ç., KÜÇÜK N. Ö., ÇELEBİOĞLU E. C., KURU ÖZ D., BİLGİÇ M. S., et al.

36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)

21. Radioembolization with 90Y Resin Microspheres and Voxel-Based Dosimetry with Integrated 90Y PET/MRI

DEMİR B., SOYDAL Ç., KÜÇÜK N. Ö., ÇELEBİOĞLU E. C., BİLGİÇ M. S., KURU ÖZ D., et al.

33rd Annual Conference of Asian Pacific Association for the Study of the Liver, Kyoto, Japan, 27 March 2024, (Full Text)

22. Hybrıd F18-FDG PET/MRI in endometrial cancer: staging accuracy, quantitative analysis, and imaging characteristics of histological subtypes

KURU ÖZ D., ARAZ M., Yılmazer Zorlu N. S., VARLI B., SOYDAL Ç., TAŞKIN S., et al.

European Congress of Radiology, ECR 2024, Austria, 28 February - 03 March 2024, (Full Text)

23. Evaluation of the success of 18F-PSMA PET/CT in the detection of prostate cancer recurrence in patients with biochemical recurrence

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.

Annual Congress of European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)